AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Titan PharmaceuticalsOutlook TherapeuticsCytRxaTyr PharmaTrovaGene
SymbolNASDAQ:TTNPNASDAQ:OTLKOTCMKTS:CYTRNASDAQ:LIFENASDAQ:TROV
Price Information
Current Price$0.28$1.02$0.31$3.71$1.19
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.21.30.71.41.9
Analysis Score3.53.50.03.33.5
Community Score2.62.62.82.32.9
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.01.03.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$1.00$8.00N/A$8.75$14.50
% Upside from Price Target252.98% upside684.31% upsideN/A135.85% upside1,118.49% upside
Trade Information
Market Cap$27.45 million$93.21 million$24.22 million$34.97 million$27.86 million
Beta0.860.091.722.321.04
Average Volume14,708,854857,228206,044295,213648,892
Sales & Book Value
Annual Revenue$3.61 million$8.15 million$250,000.00$420,000.00$250,000.00
Price / Sales7.5111.4441.7182.6152.41
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.06 per share($0.22) per share$0.45 per share$4.49 per share$0.94 per share
Price / Book4.72-4.640.690.831.27
Profitability
Net Income$-16,460,000.00$-34,520,000.00$-7,160,000.00$-23,600,000.00$-16,410,000.00
EPS($0.72)($1.98)N/A($7.03)($2.80)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-437.91%-423.83%N/A-185.14%-3,688.31%
Return on Equity (ROE)-1,909.37%N/A-43.76%-52.40%-202.00%
Return on Assets (ROA)-190.56%-160.42%-38.00%-34.32%-122.92%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.68%N/AN/A0.05%0.12%
Current Ratio2.75%0.40%7.37%4.82%2.37%
Quick Ratio2.51%0.40%7.37%4.82%2.37%
Ownership Information
Institutional Ownership Percentage3.49%6.65%N/A56.22%9.99%
Insider Ownership Percentage1.40%4.00%6.90%9.44%0.60%
Miscellaneous
Employees2356642N/A
Shares Outstanding95.66 million91.38 million33.64 million9.35 million11.01 million
Next Earnings Date8/12/2020 (Estimated)8/12/2020 (Estimated)8/14/2020 (Estimated)8/12/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.